Evidence map›Paper›PMID 40418312›Full record

ArticleApplied biochemistry and biotechnology2025

Characterization of a New Glycolipopeptide Biosurfactant Produced by a Chrysene-Degrading Strain Achromobacter aegrifaciens.

Assia Lazzem, Haykel Galai, Ahmed Landoulsi, Abdelwaheb Chatti, Alya El May

Abstract read
PubMed Publisher
In one paragraph

Article in Applied biochemistry and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Assia LazzemLaboratory of Risks Related to Environmental Stresses: Fight and Prevention, Faculty of Sciences of Bizerte, University of Carthage, 7021, Jarzouna, Tunisia. assialazzem@hotmail.com.ORCID http://orcid.org/0000-0002-4241-6464
Haykel GalaiLaboratory of Materials, Treatment and Analysis, The National Institute of Research and Physico-Chemical Analysis of Sidi-Thabet LMTA, 2020, Sidi Thabet, Tunisia.
Ahmed LandoulsiLaboratory of Risks Related to Environmental Stresses: Fight and Prevention, Faculty of Sciences of Bizerte, University of Carthage, 7021, Jarzouna, Tunisia.
Abdelwaheb ChattiLaboratory of Risks Related to Environmental Stresses: Fight and Prevention, Faculty of Sciences of Bizerte, University of Carthage, 7021, Jarzouna, Tunisia.
Alya El MayLaboratory of Risks Related to Environmental Stresses: Fight and Prevention, Faculty of Sciences of Bizerte, University of Carthage, 7021, Jarzouna, Tunisia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biosurfactants are surface-active biomolecules with emulsifying properties. These versatile compounds have numerous applications across various industries and environmental contexts, including the remediation of areas contaminated by persistent pollutants such as hydrocarbons. This study focuses on the physicochemical characterization of a biosurfactant produced by a newly identified chrysene-degrading Achromobacter aegrifaciens strain. Biosurfactant production was evaluated using the emulsification index (E24). The research determined the biosurfactant's surface tension, critical micelle concentration (CMC), and stability under different temperatures, pH levels, and salt concentrations. The chemical components of the partially purified biosurfactant were analyzed using biochemical tests, thin layer chromatography (TLC), Fourier transform infrared (FTIR), nuclear magnetic resonance (H

Indexed as

AchromobacterSurface-Active AgentsBiodegradation, EnvironmentalHydrogen-Ion ConcentrationSurface TensionTemperatureSurface-Active AgentsAchromobacter aegrifaciensCritical micelle concentrationEmulsification indexGlycolipopeptide

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.